What to Know About the New Semaglutide Pill for Obesity

JAMA 2026

View at publisher
Authors: Kate Schweitzer
DOI: 10.1001/jama.2026.0035
Cited by: 8

Abstract

This Medical News article discusses the US Food and Drug Administration approval of oral semaglutide for the treatment of obesity in adults.

Fields of Study & Subjects

Pharmacology and Obesity Treatment Diabetes Treatment and Management Bariatric Surgery and Outcomes

Publication details

Journal / source
JAMA
Publisher
American Medical Association (AMA)
Volume
335
Issue
6
Pages
478–478
Publication date
16 January 2026
Language
EN